Cardiomyopathy Arrhythmia Risk Evaluation
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 164
- 试验地点
- 1
- 主要终点
- Proportion of patients with appropriate implantable cardioverter defibrillator (ICD) shocks
研究概览
简要总结
This study will evaluate the prognostic utility of novel ECG markers of electrical instability in patients with cardiomyopathy.
详细描述
Baseline ECG markers of electrical instability will be measured in patients with cardiomyopathy. These ECG markers will be evaluated from a clinical Holter recording. All patients will have a primary implantable cardioverter defibrillator (ICD) as part of their clinical care. Patients will be followed prospectively for 2 years to evaluate the primary outcome of appropriate ICD shocks. Multivariable modelling will be performed to determine whether the ECG markers of electrical instability independently predict the primary clinical outcome.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •cardiomyopathy, primary prevention ICD
排除标准
- •brady-pacing requirement
结局指标
主要结局
Proportion of patients with appropriate implantable cardioverter defibrillator (ICD) shocks
时间窗: 2 years
Proportion is from 0 (no patients with shocks) to 100% (all patients receive shocks)
次要结局
未报告次要终点